Status: current, Primitive. Date: 31-Jan 2018. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2213261000168119 | ocrelizumab (AU substance) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2213271000168113 | ocrelizumab | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| ocrelizumab | Is a | medicinal substance | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| ocrelizumab | has intended active ingredient | True | ocrelizumab | Inferred relationship | Some | 1 |
| Ocrevus 300 mg/10 mL injection, 10 mL vial | has Australian BoSS | True | ocrelizumab | Inferred relationship | Some | 283119802 |
| Ocrevus 300 mg/10 mL injection, 10 mL vial | has intended active ingredient | True | ocrelizumab | Inferred relationship | Some | 283119802 |
| ocrelizumab 300 mg/10 mL injection, vial | has Australian BoSS | True | ocrelizumab | Inferred relationship | Some | 1642042138 |
| ocrelizumab 300 mg/10 mL injection, vial | has intended active ingredient | True | ocrelizumab | Inferred relationship | Some | 1642042138 |
This concept is not in any reference sets
FHIR